Rivastigmine improves ADLs over the course of Alzheimer's disease.

被引：0
|
作者：
Potkin, SG [1 ]
机构：
[1] Univ Calif Irvine, Irvine, CA USA
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2002年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [1] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline
    Evans, John Grimley
    Iakovidou, Vasso
    Tsolaki, Magda
    Holt, Francesca E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (02):
  • [2] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline S.
    Chong, Lee Yee
    Evans, John Grimley
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (09):
  • [3] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline S.
    Evans, John Grimley
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (04):
  • [4] Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease
    Potkin, SG
    Anand, R
    Hartman, R
    Veach, J
    Grossberg, G
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (04): : 713 - 720
  • [5] Rivastigmine three times daily improves cognition and response in Alzheimer's disease
    Farlow, Martin R.
    EVIDENCE-BASED MENTAL HEALTH, 2007, 10 (04)
  • [6] Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease.: Disease course over a two-year period under constant treatment conditions with rivastigmine
    Wobrock, T
    Retz-Junginger, P
    Retz, W
    Supprian, T
    Rösler, M
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2003, 71 (04) : 199 - 204
  • [7] Rivastigmine in the treatment of Alzheimer's disease
    Deleu, D
    EUROPEAN NEUROLOGY, 2001, 46 (02) : 111 - 111
  • [8] Evaluation of rivastigmine in Alzheimer's disease
    Nguyen, Kevin
    Hoffman, Heidi
    Chakkamparambil, Binu
    Grossberg, George T.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (01) : 35 - 48
  • [9] Rivastigmine in the pharmacotherapy of Alzheimer's disease
    Volz, HP
    Maurer, I
    PSYCHOPHARMAKOTHERAPIE, 2001, 8 (03): : 104 - 110
  • [10] An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease.
    Shua-Haim, JR
    Pass, MD
    Smith, J
    Lee, PP
    Patel, S
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S93 - S93
12345